2009
DOI: 10.1177/147323000903700632
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and Safety of Celecoxib in the Treatment of Acute Pain due to Ankle Sprain in a Latin American and Middle Eastern Population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
5
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 51 publications
0
5
0
Order By: Relevance
“…Likewise, the results obtained were similar to those reported in previous studies with oral Celecoxib. For example, in a study with a population similar to ours in which the efficacy of Celecoxib 200 mg BID and NSAIDs was compared, it was shown that Celecoxib significantly reduced pain at day 7 when it was evaluated with a VAS score [20].…”
Section: Discussionmentioning
confidence: 62%
“…Likewise, the results obtained were similar to those reported in previous studies with oral Celecoxib. For example, in a study with a population similar to ours in which the efficacy of Celecoxib 200 mg BID and NSAIDs was compared, it was shown that Celecoxib significantly reduced pain at day 7 when it was evaluated with a VAS score [20].…”
Section: Discussionmentioning
confidence: 62%
“…17,[28][29][30][31][32][33][34][35][36] All of the more recent studies were randomized, double-blind, double-dummy, parallelgroup designs. 17,[28][29][30][31][32][33][34][35][36] Half of the studies were placebo-controlled, superiority studies. 17,29,30,34,35 The majority (nine studies) had pain-on-movement intensity difference from baseline (100 mm VAS) as the primary or secondary endpoint.…”
Section: Discussionmentioning
confidence: 99%
“…17,29,30,34,35 The majority (nine studies) had pain-on-movement intensity difference from baseline (100 mm VAS) as the primary or secondary endpoint. 17,[28][29][30][31][32][33]35,36 Seven studies assessed this endpoint on either day 3 or 4. [28][29][30][31][32]35,36 With the above limitations in mind, a comparison can be made on overall clinical outcome.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nonsteroidal anti-inflammatory drugs (NSAIDs) can also be used to reduce pain, decrease swelling, and improve short-term ankle function, thus speeding recovery (1,4,7,10,15,22). Topical NSAIDs, available "over-the-counter" in most countries, are proven effective and are particularly well tolerated for the short-term management of acute mildto-moderate pain and inflammation, including soft tissue injuries such as ankle sprains.…”
mentioning
confidence: 99%